NRXP Stock Analysis: Buy, Sell, or Hold?

NRXP - NRX Pharmaceuticals, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$3.21
0.26 (8.81%) ▲
5d: +4.9%
30d: +27.38%
90d: +85.55%
HOLD
MODERATE Confidence
Protect Your NRXP Gains
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 21, 2026 5d
Smart Money Distribution

NRXP is up 4.9% this week, but smart money is buying puts. Top strike: $2.5 2026-06-18 with 492 OI. Put ratio: 69% View Scanner →

Strength: 4.4/10

Get Alerted When NRXP Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: NRXP shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$7.71
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.79
32.9% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: NRXP is currently trading at $3.21, which is considered extended relative to its 30-day fair value range of $2.45 to $3.10. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.4) compared to its historical average (11.0). Remarkably, the market is currently pricing in an annual earnings decline of 16.5% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, NRXP is in a uptrend. The price is approaching resistance at $3.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.8% recently.

Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $38.25 (+1091.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $2.45 - $3.10
Company Quality Score 60/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 55.7%

Protect Your Profits

Holding NRXP? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Price extended above range
  • NEUTRAL: Mixed technical signals (55/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+8.8%)
  • BULLISH: Trading 1091.6% below Wall St target ($38.25)

Trading Range Analysis

30-Day Trading Range $2.45 - $3.10
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $2.74
Resistance Level $3.26
Current Trend Uptrend
Technical data as of May 14, 2026

Fundamental Context

Forward P/E (Next Year Est.) 6.42
Wall Street Target $38.25 (+1091.6%)
Valuation Discount vs History -16.5% cheaper
PE vs Historical 6.4 vs 11.0 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -16.5% (market-implied from PE analysis)
1-Year Target $2.89 (-10%)
2-Year Target $2.60 (-19%)
3-Year Target $2.34 (-27%)
3-Yr Target (if PE normalizes) (PE: 6→11) $4.01 (+25%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.4 to 11.0
Stabilization Target: $5.50 (+71.3%)
PE Expansion Potential: +71.3%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 14, 2026 11:32 PM ET
Data refreshes hourly during market hours. Next update: 12:32 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for NRXP.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
29 analysts
$91 63 BUY
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$101 66 BUY
MRUS
Merus BV
STRONG BUY
17 analysts
$97 55 HOLD
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$30 58 HOLD
BHVN
Biohaven Pharmaceutical …
STRONG BUY
16 analysts
$22 54 HOLD

Advanced NRXP Option Strategies

Professional options setups generated by AI based on today's NRXP price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for NRXP

NRXP Technical Chart NRXP Price Prediction NRXP Earnings Date NRXP Investment Advisor NRXP Fair Price Analyzer NRXP Options Advisor NRXP Options Chain NRXP Options Analysis NRXP Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals